ENvue Medical (FEED) EPS (Basic) Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.15% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.72% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -1.10% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.43% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.44% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 58.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 26.49% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 5.98% |
| 10 | ENvue Medical | 2.97 Mn | 709,615.89 | -55,000.00 | -117.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -117.36% |
| Dec 31, 2025 | -141.50% |
| Sep 30, 2025 | -10.20% |
| Jun 30, 2025 | -3.46% |
| Mar 31, 2025 | -70.07% |
| Dec 31, 2024 | -127.98% |
| Sep 30, 2024 | -139.24% |
| Jun 30, 2024 | -1,295.56% |
| Mar 31, 2024 | 140.44% |
| Dec 31, 2023 | -1,192.86% |
| Sep 30, 2023 | -61.34% |
| Jun 30, 2023 | -48.12% |
| Mar 31, 2023 | -72.73% |
| Dec 31, 2022 | -102.90% |
| Sep 30, 2022 | -78.28% |
| Jun 30, 2022 | -79.80% |
| Mar 31, 2022 | -26.51% |
| Dec 31, 2021 | -292.45% |
| Sep 30, 2021 | -7.38% |
| Jun 30, 2021 | 57.47% |
| Mar 31, 2021 | -18.56% |
| Dec 31, 2020 | 26.79% |
| Sep 30, 2020 | 34.14% |
| Jun 30, 2020 | -3.57% |
| Mar 31, 2020 | 29.44% |
| Dec 31, 2019 | 12.06% |
| Sep 30, 2019 | 2.63% |
| Jun 30, 2019 | -7.17% |
| Mar 31, 2019 | -53.78% |
| Dec 31, 2018 | 39.68% |
| Sep 30, 2018 | 2.99% |
| Jun 30, 2018 | -9.14% |
| Mar 31, 2018 | 47.93% |
| Dec 31, 2017 | 63.06% |
| Sep 30, 2017 | 58.62% |
| Jun 30, 2017 | 63.59% |
| Mar 31, 2017 | 51.48% |